Wholestack: A financial services firm committed to long-term investment in developing domains.
Wholestack is an investment partner focused on backing early-stage funds globally. They invest in funds at the earliest stages of formation, with investments ranging from $1M to $30M. Their primary focus is on emerging domains that are currently considered fringe but have the potential to become mainstream, including AI and drug discovery, synthetic biology, viable therapeutics, and pre-clinical proof.
The firm's portfolio includes Allonnia, a company that has raised $30 million. Wholestack has participated in one Series A round. Their investment philosophy centers on long-term conviction and providing capital to realize the potential of developing domains. By supporting early-stage funds, Wholestack aims to play a crucial role in shaping the future of innovative industries.
WholeStack - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies1
Current Portfolio Count1
Top Investment Stages
Series A1 (100.0%)
Stage Mix
Series A 100%
Concentration shown as share of disclosed investments by stage.
